|By PR Newswire||
|March 20, 2014 10:36 AM EDT||
WASHINGTON, March 20, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America announced today that it is funding and leading the development of a first-of-its-kind tool to monitor lupus disease activity called the LFA-REAL™(Rapid Evaluation of Activity in Lupus) System. LFA-REAL will address major challenges in lupus treatment and disease management, and has the potential to greatly improve medical care and quality of life for people living with this unpredictable and misunderstood autoimmune disease.
"One of the biggest problems in patient care is the lack of tools which clinicians can use to make and assess treatment decisions," explains Sandra C. Raymond, President and CEO of the Lupus Foundation of America. "The Lupus Foundation of America is developing LFA-REAL in collaboration with a multi-stakeholder group, including top lupus experts, doctors, researchers, drug development companies, agencies of the federal government, people with lupus and health insurers. The system will engage patients as partners in their own care, enabling informed shared decisions that can improve health, identify better treatments for each person's unique situation and potentially improve insurance coverage of current and future treatments."
"We are working to solve a real concern in patient care by developing LFA-REAL," says Joan T. Merrill, MD, Head of the Clinical Pharmacology Program at the Oklahoma Medical Research Foundation and Medical Director for the Lupus Foundation of America. "Physicians in practice are being asked for accurate, validated benchmarks in quality assurance programs and to support insurance justifications for the use of expensive medications. Current tools to assess lupus disease activity are burdensome, unwieldy or are incorrectly performed by people who are not properly trained. The LFA-REAL System offers a solution by giving clinicians a simple but reliable method to quantify the progress of their complicated lupus patients."
LFA-REAL will use a series of simple questions to determine a treatment's impact on the patient's health and quality of life. It will be easy to use with web and mobile-based options.
The concerns addressed by LFA-REAL go beyond the clinic and also tackle barriers in the development of new lupus treatments. People with lupus need an arsenal of targeted, safe and more tolerable therapies to bring the disease under control and greatly improve their quality of life. LFA-REAL has the potential to provide important data that could simplify the process of approving new lupus therapies.
Furthermore, in an environment where insurance companies are critically looking at the value and cost of care, LFA-REAL can offer information that will support insurance coverage for current and new treatments.
"The increased focus on cost control has led many health insurers to mandate that doctors provide solid evidence that a drug will provide real benefit to a patient and demonstrate an effective use of health care dollars," adds Ms. Raymond. "This requirement already is creating a challenge for many healthcare providers who feel they are not properly equipped to accurately respond to this request using tools currently available. LFA-REAL will be a simple method that can show health insurers these new treatments are cost effective at managing lupus."
Over the next three years, the Foundation will lead a multi-stakeholder group to develop and test the tool at multiple clinics across the country. More information about LFA-REAL can be found on line at lupus.org/LFAREAL.
Lupus is an unpredictable and misunderstood autoimmune disease that ravages different parts of the body. It is difficult to diagnose, hard to live with and a challenge to treat. Lupus is a cruel mystery because it is hidden from view and undefined, has a range of symptoms, strikes without warning, and has no known cause and no known cure. Its health effects can range from a skin rash to a heart attack. Lupus is debilitating and destructive and can be fatal, yet research on lupus remains underfunded relative to diseases of similar scope and devastation.
About the Lupus Foundation of America
The Lupus Foundation of America is the only national force devoted to solving the mystery of lupus, one of the world's cruelest, most unpredictable and devastating diseases, while giving caring support to those who suffer from its brutal impact. Through a comprehensive program of research, education, and advocacy, the Foundation leads the fight to improve the quality of life for all people affected by lupus. Learn more about the Lupus Foundation of America at lupus.org. For the latest news and updates, follow us on Twitter and Facebook.
About the Lupus Foundation of America National Research Program
The Lupus Foundation of America National Research Program: Bringing Down the Barriers™ aggressively seeks to advance the science and medicine of lupus and to improve the quality of life for people with lupus. For nearly 40 years, research supported by the Lupus Foundation of America has led to expanded understanding of the disease and contributed to many of the lupus-related scientific breakthroughs of the past several decades.
SOURCE Lupus Foundation of America
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
Sep. 29, 2016 01:45 PM EDT Reads: 1,101
Sep. 29, 2016 01:45 PM EDT Reads: 1,759
19th Cloud Expo, taking place November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Meanwhile, 94% of enterpri...
Sep. 29, 2016 01:30 PM EDT Reads: 4,444
Businesses are struggling to manage the information flow and interactions between all of these new devices and things jumping on their network, and the apps and IT systems they control. The data businesses gather is only helpful if they can do something with it. In his session at @ThingsExpo, Chris Witeck, Principal Technology Strategist at Citrix, will discuss how different the impact of IoT will be for large businesses, expanding how IoT will allow large organizations to make their legacy ap...
Sep. 29, 2016 01:15 PM EDT Reads: 305
In his general session at 18th Cloud Expo, Lee Atchison, Principal Cloud Architect and Advocate at New Relic, discussed cloud as a ‘better data center’ and how it adds new capacity (faster) and improves application availability (redundancy). The cloud is a ‘Dynamic Tool for Dynamic Apps’ and resource allocation is an integral part of your application architecture, so use only the resources you need and allocate /de-allocate resources on the fly.
Sep. 29, 2016 01:15 PM EDT Reads: 2,904
SYS-CON Events announced today the Enterprise IoT Bootcamp, being held November 1-2, 2016, in conjunction with 19th Cloud Expo | @ThingsExpo at the Santa Clara Convention Center in Santa Clara, CA. Combined with real-world scenarios and use cases, the Enterprise IoT Bootcamp is not just based on presentations but with hands-on demos and detailed walkthroughs. We will introduce you to a variety of real world use cases prototyped using Arduino, Raspberry Pi, BeagleBone, Spark, and Intel Edison. Y...
Sep. 29, 2016 01:15 PM EDT Reads: 3,009
Sep. 29, 2016 01:00 PM EDT Reads: 1,686
Sep. 29, 2016 12:45 PM EDT Reads: 5,131
Sep. 29, 2016 12:30 PM EDT Reads: 1,743
Sep. 29, 2016 12:00 PM EDT Reads: 440
Sep. 29, 2016 12:00 PM EDT Reads: 3,139
Sep. 29, 2016 11:45 AM EDT Reads: 2,596
Sep. 29, 2016 11:30 AM EDT Reads: 2,157
Sep. 29, 2016 11:00 AM EDT Reads: 413
Sep. 29, 2016 11:00 AM EDT Reads: 3,522